To date, a large number of reports have described reprogramming many somatic cell types into induced pluripotent stem (iPS) cells, using different numbers of transcription factors and devising alternate methods of introducing the transcription factor genes or proteins into the somatic cells. Here, we describe a method using bacteriophage ΦC31 integrase to reprogram mouse embryonic fibroblasts and human amniotic fluid cells into iPS cells. These iPS cells showed morphology, surface antigens, gene expression, and epigenetic states similar to ES cells and formed teratomas with three germ layers in nonobese diabetic/severely compromised immunodeficient mice. Importantly, these iPS cells have only a single integration site in each cell line. The locations of integration favor the intergenic regions, and their distances from the adjacent genes extended from several hundred to >1 million bp. The effect of the insertion on the expression of these genes can be studied by RT-PCR. No insertion into microRNA gene loci was detected. Hence, it is possible to select cells in which adjacent gene functions are not affected, or the inserts can be removed if necessary. We conclude that phage integrase-mediated sitespecific recombination can produce iPS cells that have undisturbed endogenous gene function and could be safe for future human therapeutic application. 
To date, a large number of reports have described reprogramming many somatic cell types into induced pluripotent stem (iPS) cells, using different numbers of transcription factors and devising alternate methods of introducing the transcription factor genes or proteins into the somatic cells. Here, we describe a method using bacteriophage ΦC31 integrase to reprogram mouse embryonic fibroblasts and human amniotic fluid cells into iPS cells. These iPS cells showed morphology, surface antigens, gene expression, and epigenetic states similar to ES cells and formed teratomas with three germ layers in nonobese diabetic/severely compromised immunodeficient mice. Importantly, these iPS cells have only a single integration site in each cell line. The locations of integration favor the intergenic regions, and their distances from the adjacent genes extended from several hundred to >1 million bp. The effect of the insertion on the expression of these genes can be studied by RT-PCR. No insertion into microRNA gene loci was detected. Hence, it is possible to select cells in which adjacent gene functions are not affected, or the inserts can be removed if necessary. We conclude that phage integrase-mediated sitespecific recombination can produce iPS cells that have undisturbed endogenous gene function and could be safe for future human therapeutic application. has given stem cell research a new impetus because it allows the creation of normal and disease-specific stem cells. Initially, iPS cells were reprogrammed from mouse fibroblasts by retroviral delivery of four transcription factors: Oct3/4, Sox2, Klf4, and cMyc (1) . This groundbreaking study was followed 1 year later by the generation of human iPS cells in a similar manner (2) (3) (4) . Since then, a large number of reports have described reprogramming many somatic cell types, using different numbers of transcription factors and various methods of introducing the transcription factor genes or proteins into the somatic cells (for review, see refs. 5 and 6). The most efficient way to generate iPS cells is to introduce the transcription factor genes with integrating viral vectors. A concern with this method is that integration of the viral vector into random chromosomal locations may disturb vital gene functions (7) . This complication is even more problematic if the iPS cells are to be used for a therapeutic purpose. Alternate methods that have been reported include using lentiviral vectors with limited insertion sites (8) (9) (10) , nonintegrating vectors such as plasmid (11) , adenoviral (12) and OriP/Epstein-Barr nuclear antigen-1 (EBNA1)-based episomal vectors (13) , or piggyBac vectors for insertion into transposons (14) (15) (16) (17) . Mouse and human iPS cells also have been generated with direct delivery of recombinant proteins, but the efficiency apparently is quite low (18, 19) . Although a large number of protocols have been described, it is not yet known which method will be most suitable for generating iPS cells for future applications in human therapy.
Bacteriophage integrates into the bacterial chromosomes by reactions catalyzed by the enzyme integrase using short sequences, known as the phage attachment site (attP) and the bacterial attachment site (attB), respectively, for recombination. Calos and her colleagues (20) (21) (22) (23) (24) have shown that sequences homologous to attP and attB sites, called "pseudo attP" and "pseudo attB," are present in the mammalian genome, and that foreign DNA can be integrated specifically into these sites with phage integrase. The integration usually is a single copy per cell. The sites often are found in the intergenic regions and less frequently in introns. Phage integrase may offer an alternate method of producing iPS cells without interfering with endogenous gene functions.
Our laboratory has been interested in studying sickle cell anemia and thalassemia for some years. iPS cell therapy appears to provide a good means for treating these patients, because the iPS cells can be made from the patient's somatic cells, with the mutations in the β-globin gene corrected, and the cells can be differentiated into hematopoietic cells to treat the patient. A mouse model of sickle cell anemia has been corrected in this manner (25) . Here, we describe a method of reprogramming that may be useful for future application in such human work. We used bacteriophage integrase to target transcription factor genes into mouse and human somatic cells to generate iPS cells successfully and showed that it is possible to select iPS cell clones in which the integrations do not affect gene functions.
Results

Construction and Test of the Tetracycline-Inducible Polycistronic
Constructs. We used two polycistronic constructs that we made containing the transcription factor genes OCT3/4, SOX2, KLF4, and cMYC (O,S,K,M) joined by 2A peptides together with the GFP gene (G) at the 3′end. The two constructs, OSKM(G) and OKSM(G), differ in gene order. Because the phage integrasemediated integration usually is a single copy per cell, we used the tetracycline (Tet) Tet-On Advanced system (Clontech) to increase gene expression by placing this construct under the Tet response element (TRE), TRE-Tight promoter. This construct, together with a CAG (modified chicken beta-actin promoter with cytomegalovirus immediate early enhancer) promoter-driven Tet transactivator (rtTA) (26) , was cloned into a single vector with the polycistronic construct flanked by the chicken insulator to minimize transcriptional interference. The constructs then were ligated to a plasmid, pJTI-Fast-DEST (Invitrogen), which contained the attB site to promote recombination with pseudo attP sites in the mammalian genome (Fig. 1A) .
To test the ability of the Tet-On system to generate iPS cells, we transiently transfected these two composite constructs (hereafter referred to as "OSKM" and "OKSM") into HEK 293 cells and observed the expression of the four factors and GFP on doxycycline induction (Fig. S1A) . Then 5 μg of DNA was electroporated into 10 6 MEF cells, and culture with doxycycline was continued for 20 d. iPS cell colonies were formed with both the OKSM and OSKM constructs (Fig. S1B) . Southern blot analysis showed that 70% of the colonies had single integration sites, indicating that a single copy was capable of generating iPS cells with doxycycline induction (Fig. S1C) . Because the purpose of this experiment performed without integrase was to test the two constructs, and the integrations were not expected to be sitespecific, these colonies were not analyzed further.
Reprogramming MEF with Integrase-Mediated attB Site-Specific Integration. To test the effect of integrase on reprogramming, 0.5 μg of OSKM or OKSM was electroporated into 10 6 MEF cells in the presence of 10 μg of an expression plasmid for ΦC31 integrase (Invitrogen) or 10 μg of an irrelevant plasmid. To minimize nonspecific integration, we used 1/10 of the amount of construct used in the previous experiments without integrase. Beginning 1 d after electroporation, the cells were cultured with 2 μg/mL of doxycycline for 10 d and with 0.4 μg/mL of doxycycline for another 4-10 d. On day 20, 29 colonies were detected on the culture with the integrase plasmid, but only one was detected on the culture with the irrelevant plasmid. Sixty percent of these colonies became stable iPS cells and had demethylation patterns characteristic of mouse ES cells (Fig. S2A) . They also expressed the pluripotency markers Nanog and SSEA1 (Fig. 1B) , were able to differentiate into three germ layers in vitro (Fig.  S2C) , and formed teratomas in immunodeficient mice (Fig. 1C) . Their abilities for chimera formation and germ line transmission are being analyzed. GeneChip microarray analyses showed that the global gene expression patterns are similar in mouse iPS cells and mouse ES cells but are different from those in MEF cells (Fig. S2B ). Among 28,766 genes analyzed, 2,312 genes showed more than twofold differential expression between iPS cells and MEF, and 2,036 genes showed more than twofold differential expression between mouse ES cells and MEF. In contrast, only 75 genes showed more than a twofold difference between iPS cells and mouse ES cells (Dataset S1).
Southern blot analysis of the genomic DNA of these iPS cell clones digested with restriction enzyme SspI showed that the inserts appeared only as single bands, indicating that there is only one insertion site in each clone (Fig. 1D) . The single-site insertion was confirmed by FISH in several of the clones (Fig. 1E) .
Determination of the Integration Sites. Integration sites were determined by rescuing the plasmid with the adjacent genomic sequences. Genomic DNAs were digested with Nhe1 or AvrII that did not cut the composite constructs. The fragments were recircularized, transformed into Escherichia coli, and cultured under ampicillin selection. The plasmids were recovered, and the DNA was digested with BamH1. In addition to the 4.3-and 2.7-kb bands generated from the three BamH1 sites in the composite constructs (Fig. 1A) , one or more bands of variable size were obtained, depending on the absence or presence of BamH1 sites within the circularized segments of the genomic DNA ( Fig. 2A , Left). The junctions between the inserts and the adjacent genomic sequence were sequenced ( Fig. 2C ) using primer P1 (ϕC31attB; Invitrogen) located at the attB site and primer P2 (attB4211) flanking the attB region (Table S1 ), and the sequences were analyzed with BLAST (GenBank) for the chromosome inserted, the closest adjacent genes, and the distance of the genes from the insertion ( Table 1) . Six of the clones showed insertion into the intergenic regions on four chromosomes, numbers 2, 6, 14, and 15. The closest known gene was 422 bp away, and the farthest was 160 kb away. Because the insertion into chromosome 15 of cell line mIntOK8 was closest to two flanking genes, squalene epoxidase and hypothetic protein LOC223593, we tested the effect of the insertion on the expression of these genes using RT-PCR and compared the expression of these two genes with cell line mIntOK7, in which the insertion occurs on chromosome 4, as control. We found the levels of gene expression in both differentiated and undifferentiated cells were not different in these two cell lines (Fig S2D) , indicating the insertion did not alter the expression of the flanking genes. One clone was inserted into intron 3 of the vacuolar protein-sorting 13D gene on chromosome 4. It is interesting to note that three insertions occurred at the same site on chromosome 14 by sequencing and at band 14B as single insertion by FISH analysis (Fig. 1E) . The sequences flanking the OKSM and OSKM insertions (mIntOS16 and mIntOK2) were identical, but they can be distinguished by digestion with Sph1 in the KLF4 gene, yielding different patterns (Fig. 2B) . The two OSKM clones (mIntOS1 and mIntOS16) had sequence differences at the junctions between the genomic sequence and the attB arms. We conclude that the frequent insertion at this site results from the greater homology of this pseudo attP site to the wild-type attP sequence (20) as compared with the other insertion sites in the mouse genome (Fig. 2D) . We also noticed that in clone mIntOS4 the insertion site in mouse chromosome 2 was identical to the pseudo attP site mpsL1, which is reported to be the predominant insertion site in mouse liver cells (27) .
Reprogramming Human Cells to iPS Cells with Site-Specific Integrase.
Previously, we showed that amniotic fluid (AF) cells obtained for prenatal diagnosis can be reprogrammed into iPS cells (28) . We suggested that when a fetus has been diagnosed as having a serious genetic illness, reprogramming the AF cells used for diagnosis into iPS cells may provide a means for early treatment of the disease. Early treatment may forestall or arrest organ damage, especially in inherited metabolic diseases in which damage may begin early.
We tested whether phage integrase can mediate site-specific insertion into human AF cells. We transfected 10 6 cells with 0.25 μg of OKSM and 5 μg of the integrase-expressing plasmid using the Nucleofector II (Lonza) and 24 h later added doxycycline (2 μg/mL). iPS-like colonies began to appear on day 9. On day 16, because the colonies seemed to have matured, we split the cultures. Doxycycline treatment was continued in one culture and was withdrawn from the other. At days 35-40, four colonies were selected from the former group. The iPS cell-like colonies cultured without doxycycline flattened and reverted to a fibroblastlike appearance. When doxycycline treatment was resumed on day 30, two clones regained the morphology of iPS cells and were harvested on day 60 (Fig. 3A) . These culture conditions show that continued culture with doxycycline is essential and that longer periods for reprogramming are required, similar to other protocols for reprogramming human cells. The iPS cells reprogrammed from AF cells had pluripotency markers (Fig. 3B) , gene expression profiles (Fig. S3A) , and demethylation patterns (20) , or between 28-nt consensus pseudo attP sequences (23) , and the 50-nt genomic sequences spanning the insertion site of the five mouse and three human chromosomes described in Table 1 . Mouse chromosome 14, which was inserted three times, has the best homology to the wild-type attP sites. Human chromosome 3, with one insertion, has a high score relative to the pseudo attP site.
( Fig. S3B ) and were capable of differentiating into three germ layers both in vitro and in vivo (Fig. S3C and Fig. 3C ). These cell lines were cultured continuously for more than 20 passages and remained ES cell-like in morphology, indicating that they possess self-renewal properties.
The integrants and the flanking genomic sequences of the six iPS cell clones we obtained were rescued as described for MEF cells ( Fig. 2A, Right) . Sequence analysis showed that the three clones inserted into chromosome 6 had identical sequences, indicating that they may have been derived from the same parental clone. The three independent clones had insertions in chromosomes 6, 2, and 3, all at intergenic regions. The distances from known genes varied from 7.5 kb to 1.2 Mb ( Table 1 ). The karyotypes of two clones (AFIntOK-2 and -3) were normal 46,XX (Fig. S3D) . However, the third clone (AFIntOK5) with chromosome 3 insertion had a 3;13 translocation (Fig. S3E) . Whether this translocation is the direct result of integrase-mediated integration is not known (Discussion). Nevertheless these results show that human iPS cells can be generated by ΦC31 integrasemediated pseudo attP site-specific integration.
Discussion
These studies show that the phage integrase system can be used to generate iPS cells from mouse and human fetal somatic cells. The integrations favor the intergenic regions; of the 10 mouse and human iPS cell clones generated, only one was inserted into an intron. The observation that three separate iPS cell clones were generated by insertion into the same pseudo attP sites on mouse chromosome 14 reinforces the site-specificity of this system. One of the pseudo attP sites used for integration in this study is identical to the mpsL1 site, which is the predominant site in mouse liver cells found by Olivares et al. (27) when they delivered a plasmid containing attB and the expression cassette for hFIX into the liver of mice.
The relationship of one line with chromosomal translocation to integrase expression is not clear. It has been shown that continued expression of phage integrase can induce chromosomal rearrangement (29) (30) (31) . In our experiments we used transient expression of the integrase plasmid. Even though the hygromycin resistance gene is contained in the Invitrogen vector that we ligated to the expression cassette, we did not use hygromycin selection at any time in these experiments. We tested by Southern blot to see if the integrase gene has been integrated stably into this iPS cell line and did not find its integration. Hence, the continued expression of integrase was unlikely. It has been postulated that integrase-mediated translocation would result in two different chromosomes on either side of the inserted sequence, or, alternately, that the crossover would occur at two different pseudo attP sites from different chromosomes (24) . In the AFIntOK5 iPS line, because the sequences flanking both sides of the insertion are those of chromosome 3 (not chromosome 13 on one side), the translocation must have occurred some distance from the insertion site. Hence it is not clear in this instance if the translocation was the direct result of the insertion event, the effect of integrase expression, or a translocation that sometimes is seen with reprogramming and cell culture.
The integrase-mediated reprogramming is similar to the piggyBac transposon method in that both yield stable transformants without viral vectors. Unlike plasmid methods, which require repeated transfections, both integrase-mediated reprogramming and the piggyBac transposon method can reprogram somatic cells successfully with a single transfection procedure. The integrase method we use persistently gives a single integrant, whereas transposon reprogramming produces cells with a few to multiple integration sites. Also, the pseudo attP sites usually are located in the intergenic region, whereas transposons are widely scattered in the mammalian genome. It has been shown that when transposon-mediated integration has occurred in one or two locations in mouse iPS cells, the integrants can be removed using transposase without leaving any footprint (16, 17) . In contrast, removal of the integrase-mediated integrants with Cre-Lox will result in some change in the genomic attP sites because of recombinations with incomplete homology with the attB sequence. Hence, it will be interesting to compare the two methods in future studies.
Another advantage of the integrase system for potential future use in cell therapy is that the distance of the single insertion from genes of known and unknown function can be determined precisely. Hence, it will be possible to determine if the insertion affects the expression of these genes. We selected one cell line where the insertion is closest to the known genes on either side. RT-PCR showed that the expression of these neighboring genes was not affected even after in vitro differentiation into three germ layers (Fig. S2 C and D) . The expression of neighboring genes also can be checked after the iPS cells have been differentiated into specific tissues. Another possible concern of the integration is that the insertion may affect the expression of microRNA. We searched the University of California, Santa Cruz genome base and did not find any known microRNA gene loci at the insertion sites of these clones. If therapeutic use is to be considered, iPS cell clones with insertions far away from genes can be chosen for further investigation, and those with insertions close to genes or into introns or with chromosomal translocations can be discarded. By assessing these criteria, it will be possible to select iPS cell clones that are suitable for future human applications. Many studies have shown that cell types strongly influence the efficiency and kinetics of the process of reprogramming. Some stem cells, such as mouse neural stem cells, need as few as one or two factors for reprogramming (32, 33) . Adipose stem cells and keratinocytes have been reported to be easier to reprogram than fibroblasts (34-36). We also found in our previous study that two factors, Oct3/4 and Sox2. were able to reprogram AF cells into iPS cells using retroviral vector delivery (28) . Because the AF cells we used in this study could be mixtures of different cell populations, we could not identify the origin of the iPS cells by cell type. Recently, it has been reported that blood cells may be a good source for generating iPS cells (37) (38) (39) (40) (41) .
As described with other protocols, integrase-mediated reprogramming is less efficient in human cells than in mouse cells. Recent reports show that efficiency can be increased by suppressing the p53-p21 pathway (42) (43) (44) or the Ink4/Arf locus (45, 46) or by the addition of vitamin C (47). Starting with a stem cellrich population and using newly improved integrase (48) also may improve reprogramming efficiency. We are investigating these approaches, because we believe integrase-mediated sitespecific recombination can provide iPS cells that could be safe for future human application.
Materials and Methods
Constructing the Reprogramming Constructs. Five steps were used to make the pJTI-Tet-On-Ins-OSKMG (OSKM) and pJTI-Tet-On-Ins-OKSMG (OKSM) constructs that incorporated Tet-On Advanced (Clontech), CAG promoter from pCAGGS (a gift from Junichi Miyazaki Osaka University, Osaka), bovine growth hormone (BGH) poly(A) from pBud C4.1 (Invitrogen), the chicken β-globin 5′ HS4 insulator element from pAC668 (a gift from D. M. Bodine, National Institutes of Health, Bethesda), two polycistron constructs encoding human cDNA of Oct4, Sox2, Klf4, and cMyc, and GFP connected by four 2A peptides and pJTIFast-DEST vector (Invitrogen). The size of the final constructs is 16,707 bp. Details of construction procedures are given in SI Materials and Methods.
MEF and Amniocyte Preparation and Cell Culture. MEF were prepared from embryos 15.5 d postconception. Embryos were dissected to remove heads and all soft tissues from chest and abdominal cavities, washed three times with 1× PBS, rinsed well, and digested in trypsin solution (0.25% trypsin, 0.1% EDTA; 3 mL per embryo) for 30 min at 37°C and 5% CO 2 . Trypsinization was stopped by adding MEF medium [10% FBS, 1 mM of glutamine, 0.1 mM of nonessential amino acids solution (NEAA), penicillin-streptomycin, and 55 μM of 2-mercaptoethanol in DMEM], and cells were recovered by centrifugation for 10 min at 200 × g. Pellets were resuspended in MEF medium, plated on 10-cm plates, and incubated at 37°C and 5% CO 2 overnight. We used passage 3-5 MEF for reprogramming experiments.
Human amniocytes were obtained anonymously from clinical samples and were maintained in AmnioMAX (Invitrogen) before use as previously described (28) .
Plasmid Transfection and Reprogramming MEF and Human Amniocytes. For MEF, we used a 300-400 V, 500 capacitance Bio-Rad electroporator for transfection. We Alkaline Phosphatase and Immunofluorescence Staining. Alkaline phosphatase staining was performed with the alkaline phosphatase detection kit (Chemicon) according to the manufacturer's protocol. Immunofluorescence staining was performed using the following primary antibodies: for mouse iPS cells, Nanog (Abcam) and SSEA-1(Developmental Studies Hybridoma Bank); for human iPS cells, Nanog (R&D), SSEA-4 (Abcam), SSEA-3(Chemicon), Tra-1-60 (Chemicon), and Tra-1-81 (Chemicon). The staining condition was described previously (28) .
Southern Blot Analysis. SspI-digested genomic DNA from mouse and human iPS colonies was separated on a 0.8% agarose gel and transferred to GeneScreen Plus hybridization transfer membrane (PerkinElmer). DNA was hybridized with a digoxigenin-labeled OCT3/4 cDNA full-length probe amplified by primers (OCT3/4 sense and OCT3/4 antisense), using Dig-dUTP-incorporated PCR products (Roche). The hybridization signals were detected using the DIG Nucleic Detection Kit (Roche).
Integration Site Analysis. To recover integrated OK or OS plasmids along with flanking genomic sequences, 1 μg of genomic DNA was digested with a restriction enzyme (NheI or AvrII) that did not cut the plasmid itself. Digested DNAs were self-ligated using T4 ligase (Invitrogen) diluted 10 times to favor monomer circularization. Ligated products were purified with phenolchloroform and ethanol precipitation. A portion (25%) of ligation DNA was electroporated into library-quality, competent E. coli cells (One Shot GeneHoges; Invitrogen). Cells were plated on Ampicillin LB agar plates. Grown colonies were selected, and plasmid DNA was prepared for confirmation by restriction enzyme BamH1 and subjected to sequencing analysis using Amp3342F, P2 (attB4211 R) (Table S1 ) and P1 (ϕC31attB) as recommended by the manufacturer (Invitrogen). The sequencing data were analyzed using BLAST to match the sequences in the mouse and the human genome. The multiple sequence alignments were performed using the ClustalW2 program (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
FISH and Chromosome Analysis. FISH slides were pretreated with 2× SSC for 2 min at 73°C, 0.5 mg/mL of pepsin (Sigma) in 0.01 N of HCl for 5 min at 37°C and in 10% phosphate buffered formalin (Fisher Scientific) for 5 min at room temperature, followed by dehydration in 70%, 85%, and 100% ethanol for 1 min each at room temperature. One microgram of pInsCAG-Tet-On plasmid was labeled using the BioPrime DNA Labeling System (Invitrogen) according to the manufacturer's protocol. Labeled DNA was precipitated with 2 μg of mouse Cot1 DNA (Invitrogen) and 5 μg of sheared salmon sperm DNA (Eppendorff) and was dissolved in 10 μL of hybridization mix (50% formamide, 10% dextran sulfate, and 2× SSC). The probe was denatured for 5 min at 75°C, reannealed for 30 min at 37°C, applied to pretreated FISH slides, and codenatured with the slides for 5 min at 75°C. After overnight hybridization at 37°C, slides were washed in 0.4× SSC/0.3% Nonidet P-40 (Boehringer Mannheim GmbH) for 2 min at 73°C and with 2× SSC/0.1% Nonidet P-40 for 1 min at room temperature. Avidin-fluorescein (Roche) was applied to the FISH slides according to the manufacturer's protocol. Cells were counterstained with DAPI II (Abbott Molecular). FISH results were documented and analyzed using the CytoVision system (Applied Imaging). For chromosome analysis, iPS cells were treated with 10 ng/mL of Colcemid (Invitrogen) overnight at 37°C. Cells were harvested and G-banded according to standard cytogenetic protocols (49) .
Metaphase cells were analyzed and karyotyped using CytoVision system (Applied Imaging).
Teratoma Formation and Analysis. Mouse iPS cells were dissociated with 0.05% trypsin/EDTA (Invitrogen) and collected with mouse ES medium. One well of a six-well plate containing about 10 6 mouse iPS cells was suspended in 200 μL PBS, and the cells were injected s.c. into the dorsal flank of nonobese diabetic/severely compromised immunodeficient (NOD-SCID) mice (Jackson Laboratory). Tumors formed in 3-4 wk, were removed before they exceeded 1.5 cm in diameter, and were fixed in 10% formalin, sectioned, and stained with H&E.
Human iPS cells from one 10-cm dish were collected by collagenase IV treatment (1 mg/mL) and were scraped and collected in DMEM/F12. Cells were washed twice with DMEM/F12 and aggregated by spinning at 200 × g for 5 min and were resuspended in 200 μL of DMEM/F12; then 100 μL of matrix gel was added. The total 300-μL suspension was injected i.m. into the hind legs of NOD/SCID mice. Tumors formed in 4-10 wk, were removed before they exceeded 1.5 cm in diameter, and were fixed in 10% formalin for H&E staining.
